Testing effectiveness (Phase 2)Study completedNCT01642186
What this trial is testing
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
Who this might be right for
Fibrolamellar CarcinomaFibrolamellar Liver Cancer
Memorial Sloan Kettering Cancer Center 28